Current role
Joana Goncalves
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joana Goncalves
Oruka Therapeutics, Inc. reported in an 8-K filed September 5, 2024 that Joana Goncalves was appointed Chief Medical Officer, effective August 29, 2024. Tvardi Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that Joana Goncalves resigned as Chief Medical Officer, effective April 16, 2024. The proxy statement of Oruka Therapeutics, Inc. reports total compensation of $2,338,593 for Joana Goncalves in fiscal 2025, including a base salary of $474,000. Disclosed compensation is on record for 6 fiscal years.
“On August 29, 2024, the Board appointed Lawrence Klein as the Company’s President and Chief Executive Officer, Arjun Agarwal as the Company’s Senior Vice President, Finance and Treasurer, Joana Goncalves as the Company’s Chief Medical Officer and Paul Quinlan as General Counsel and Secretary, each to serve at the discretion of the Board.”
“On March 19, 2024, Dr. Joana Goncalves, the Chief Medical Officer of Cara Therapeutics, Inc. (the “Company”), informed the Company of her intention to resign from her role effective April 16, 2024, to pursue another opportunity.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Oruka Therapeutics, Inc. (ORKA)
Proxy statement
CurrentStart not stated–present
-
Tvardi Therapeutics, Inc. (TVRD)
Proxy statement
Start not stated–2024-04-16
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Oruka Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Lawrence Klein CEO, Board Member
- Thomas A. Keuer CEO
- Samarth Kulkarni Chairman, Board Member
- C. Jeff Dekker CFO
- C. Jeffrey Dekker CFO
- Laura Sandler COO
- Former Secretary General Counsel
- Paul Quinlan General Counsel
- Anders Hove Board Member
- Cameron Turtle Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Oruka Therapeutics, Inc. (ORKA) | Chief Medical Officer | $474,000 | $2,338,593 |
| 2024 | Oruka Therapeutics, Inc. (ORKA) | Chief Medical Officer | $155,854 | $317,986 |
| 2023 | Tvardi Therapeutics, Inc. (TVRD) | former Chief Medical Officer | $500,240 | $1,273,996 |
| 2022 | Tvardi Therapeutics, Inc. (TVRD) | former Chief Medical Officer | $481,000 | $1,550,355 |
| 2021 | Tvardi Therapeutics, Inc. (TVRD) | Chief Medical Officer | $465,000 | $1,736,943 |
| 2020 | Tvardi Therapeutics, Inc. (TVRD) | Chief Medical Officer | $451,200 | $1,338,702 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.